Methylphenidate improves HIV-1-associated cognitive slowing

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 13, Issue 2, 2001, Pages 248-254

  Hinkin, C H ^a   Castellon, S A ^a   Hardy, D J ^a   Farinpour, R ^a   Newton, T ^a   Singer, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

EID: 0034980889     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.13.2.248     Document Type: Article

References (34)

1. Neuropsychological and neuropsychiatric aspects of HIV infection in adults
2. HIV neurocognitive disorders
3. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals
4. Depressive symptoms in patients with HIV infection
5. Mood disorders in HIV infection: Prevalence and risk factors in a nonepicenter of the AIDS epidemic
6. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection
7. Psychological sequelae of HIV infection and AIDS: Review of empirical findings
8. Computerized testing to assess cognition in HIV-positive individuals
9. Cognition and immune function in HIV-1 infection
10. Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men
11. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals
12. Performance of patients with early HIV-1 infection on the Stroop task
13. Decision-making speed in HIV-1 infection: A preliminary report
14. Cerebrospinal fluid biogenic amine metabolites in patients with AIDS
15. Cerebrospinal fluid dopamine in HIV-1 infection
16. 1 receptors in the prefrontal cortex
17. Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion
18. Covert orienting of attention in the rat and the role of striatal dopamine
19. Reduced working memory span in Parkinson's disease: Evidence for the role of a frontostriatal system in working and strategic memory
20. Impaired simultaneous cognitive task performance in Parkinson's disease: A dopamine-related dysfunction
21. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review
22. Treatment of chronic post-traumatic organic brain syndrome with dextroamphetamine: First reported case
23. Cognitive impairment due to AIDS-related complex and its response to psychostimulants
24. Effects of methylphenidate in HIV-related depression: A comparative trial with desipramine
25. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment
26. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study
27. Dual-task performance in HIV-1 infection
28. Neuropsychological abnormalities among HIV-infected individuals in a community-based sample
29. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
30. Effects of two counter-acting stresses on the reaction processes
31. Psychostimulant response in AIDS-related complex patients
32. Successful methylphenidate treatment of apathy after subcortical infarcts
33. Decline in cognitive processing speed as a mediator of verbal decline in HIV
34. Cognitive speed as a mediator of HIV-related cognitive decline